Company News
https://chimebiologics.com/wp-content/uploads/2024/10/EUChina-BBF24-Key-Visual-1-副本.png
542
1200
chi9iua
https://chimebiologics.com/wp-content/uploads/2020/03/logo-ch-en-257.png
chi9iua2024-10-08 11:27:452024-10-10 09:28:44Europe-China Biotech Business Forum 2024
https://chimebiologics.com/wp-content/uploads/2024/09/YXH_20282-scaled.jpg
1707
2560
chi9iua
https://chimebiologics.com/wp-content/uploads/2020/03/logo-ch-en-257.png
chi9iua2024-09-30 09:50:202025-06-12 13:09:45Chime Biologics Successfully Hosts Fuel BioGrowth Chime Day 2024 Event
https://chimebiologics.com/wp-content/uploads/2024/05/3z-1.png
383
900
chi9iua
https://chimebiologics.com/wp-content/uploads/2020/03/logo-ch-en-257.png
chi9iua2024-09-18 17:04:062025-06-12 13:22:53A Brief introduction on the Challenges and Strategies in Antibody Drug Production
https://chimebiologics.com/wp-content/uploads/2024/08/封面图-鼎康生物17-1.png
320
750
chi9iua
https://chimebiologics.com/wp-content/uploads/2020/03/logo-ch-en-257.png
chi9iua2024-08-14 15:50:382025-06-12 13:34:33pilot-plant-of-chime-biologics
https://chimebiologics.com/wp-content/uploads/2024/03/9767d405-4a42-4920-bf40-d2de7d681a83.png
383
900
chi9iua
https://chimebiologics.com/wp-content/uploads/2020/03/logo-ch-en-257.png
chi9iua2024-07-01 15:53:362024-07-02 10:59:11Chime Day 2024
https://chimebiologics.com/wp-content/uploads/2024/07/0705-鼎康文章中文稿-题图.jpg
501
1179
chi9iua
https://chimebiologics.com/wp-content/uploads/2020/03/logo-ch-en-257.png
chi9iua2024-06-18 10:19:472025-06-12 13:56:43Going Global - Chime Biologics Embraces Innovation and Quality with Partners
https://chimebiologics.com/wp-content/uploads/2024/05/3z-1.png
383
900
chi9iua
https://chimebiologics.com/wp-content/uploads/2020/03/logo-ch-en-257.png
chi9iua2024-05-23 18:36:522025-06-12 14:00:34(中文) 生物类似药中美欧法规速递
https://chimebiologics.com/wp-content/uploads/2024/04/Collaborative-whitepaper.jpg
383
900
chi9iua
https://chimebiologics.com/wp-content/uploads/2020/03/logo-ch-en-257.png
chi9iua2024-04-19 17:46:332025-06-16 18:50:02Whitepaper | Immunogenicity of Innovative and Biosimilar Monoclonal Antibodies